(1)
Herschorn, S.; Nazir, J.; Ramos, B.; Hakimi, Z. Cost-Effectiveness of Mirabegron Compared to Tolterodine ER 4 Mg for Overactive Bladder in Canada. CUAJ 2017, 11, 123-30.